Enovix Co. (NASDAQ:ENVX - Free Report) - Research analysts at Cantor Fitzgerald issued their FY2026 EPS estimates for shares of Enovix in a report released on Monday, June 9th. Cantor Fitzgerald analyst D. Soderberg expects that the company will post earnings per share of ($0.97) for the year. Cantor Fitzgerald currently has a "Overweight" rating and a $30.00 price target on the stock. The consensus estimate for Enovix's current full-year earnings is ($1.01) per share.
A number of other analysts have also recently weighed in on the stock. B. Riley decreased their price target on shares of Enovix from $17.00 to $12.00 and set a "buy" rating for the company in a research note on Tuesday, April 29th. JPMorgan Chase & Co. decreased their price target on shares of Enovix from $10.00 to $9.00 and set an "overweight" rating for the company in a research note on Thursday, May 1st. Benchmark decreased their price target on shares of Enovix from $25.00 to $15.00 and set a "buy" rating for the company in a research note on Tuesday, April 15th. Craig Hallum decreased their price target on shares of Enovix from $20.00 to $18.00 and set a "buy" rating for the company in a research note on Thursday, February 20th. Finally, TD Securities decreased their price target on shares of Enovix from $10.00 to $7.00 and set a "hold" rating for the company in a research note on Thursday, May 1st. Three analysts have rated the stock with a hold rating and eight have assigned a buy rating to the company. According to data from MarketBeat.com, Enovix has a consensus rating of "Moderate Buy" and a consensus price target of $17.27.
Read Our Latest Research Report on ENVX
Enovix Stock Up 0.7%
Shares of NASDAQ ENVX traded up $0.06 during mid-day trading on Tuesday, reaching $8.68. The company had a trading volume of 3,650,747 shares, compared to its average volume of 5,944,493. The company has a current ratio of 3.77, a quick ratio of 3.61 and a debt-to-equity ratio of 0.99. The firm has a 50 day simple moving average of $7.06 and a two-hundred day simple moving average of $8.94. The stock has a market cap of $1.67 billion, a P/E ratio of -5.99 and a beta of 2.00. Enovix has a 52-week low of $5.27 and a 52-week high of $18.68.
Institutional Trading of Enovix
Several hedge funds and other institutional investors have recently made changes to their positions in the stock. Vanguard Group Inc. lifted its stake in shares of Enovix by 15.1% in the fourth quarter. Vanguard Group Inc. now owns 15,773,464 shares of the company's stock valued at $171,458,000 after purchasing an additional 2,063,631 shares during the period. Electron Capital Partners LLC lifted its stake in shares of Enovix by 18.6% in the first quarter. Electron Capital Partners LLC now owns 6,712,763 shares of the company's stock valued at $49,272,000 after purchasing an additional 1,054,029 shares during the period. Geode Capital Management LLC increased its holdings in Enovix by 6.6% during the 4th quarter. Geode Capital Management LLC now owns 3,818,827 shares of the company's stock valued at $41,520,000 after acquiring an additional 235,142 shares in the last quarter. Driehaus Capital Management LLC increased its holdings in Enovix by 1.8% during the 1st quarter. Driehaus Capital Management LLC now owns 2,323,612 shares of the company's stock valued at $17,055,000 after acquiring an additional 41,559 shares in the last quarter. Finally, Fred Alger Management LLC increased its holdings in Enovix by 21.5% during the 1st quarter. Fred Alger Management LLC now owns 2,233,446 shares of the company's stock valued at $16,393,000 after acquiring an additional 394,532 shares in the last quarter. Institutional investors and hedge funds own 50.92% of the company's stock.
About Enovix
(
Get Free Report)
Enovix Corporation designs develops and manufactures silicon-anode lithium-ion batteries. It serves wearables and IoT, smartphone, laptops and tablets, industrial and medical, and electric vehicles industries. The company was founded in 2007 and is headquartered in Fremont, California.
Featured Stories

Before you consider Enovix, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Enovix wasn't on the list.
While Enovix currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Looking to profit from the electric vehicle mega-trend? Enter your email address and we'll send you our list of which EV stocks show the most long-term potential.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.